HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan

  • Scheme Category:  
  • Equity Scheme >  
  • Sectoral/Thematic Funds
NAV: ₹ 19.567 ↑ 1.69%
[as on 6 May, 2026]

NAV chart

SMA (Simple Moving Average)

  • 50 SMA
  • 100 SMA
  • 200 SMA
  • 400 SMA

Returns

CAGR returns till date

CAGR returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan and its peers as on 6 May, 2026
NameYTD1D1W1M3M1Y3Y5Y7Y10Y
HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan 10.84% 1.69% 4% 12.65% 13.02% 20.35%----
SBI CONSUMPTION OPPORTUNITIES FUND - DIRECT PLAN - GROWTH -4.16% 0.71% 0.2% 7.63% -0.15% -2.63% 12.57% 16.83% 15.57% 16%
SBI ESG Exclusionary Strategy Fund - Direct Plan -Growth -4.79% 1.29% 0.8% 7.64% -3.08% 3.05% 13.02% 12.21% 13.05% 13.31%
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH 8.33% 1.61% 3.72% 10.83% 10.77% 9.26% 27.44% 17.03% 22.34% 13.99%
SBI INFRASTRUCTURE FUND - DIRECT PLAN - GROWTH 3.7% 0.3% 0.59% 14.47% 4.83% 9.37% 21.99% 21.72% 19.97% 16.9%
SBI PSU Fund - DIRECT PLAN - GROWTH 7.09% 1.05% -0.19% 7.83% 2.87% 21.25% 32.17% 27.94% 21.02% 17.03%

Discrete returns (yearly)

Year2016201720182019202020212022202320242025
Returns-------- 52.37% 1.73%

Discrete returns (monthly)

MonthJul 2025Aug 2025Sep 2025Oct 2025Nov 2025Dec 2025Jan 2026Feb 2026Mar 2026Apr 2026
Returns 5.33% -1.45% -1.45% 2.16% 1.22% -1.38% -4.65% 6.99% -4.36% 7.84%

Returns from spefic dates

DescriptionCAGR returns from 26 Sep 2024 (Nifty 50 2024 high)
Returns 12.35%

Portfolio

Asset allocation

EquityDebtRealestateCommoditiesCash & Equivalents
98.52% 0.00% (Arbitrage: 0.00%) 0.00% 0.00% 1.48%

Equity

NameSymbol / ISINSectorWeight %
Sun Pharmaceutical Industries Ltd.SUNPHARMA (INE044A01036)Pharmaceuticals & Biotechnology10.20%
Divis Laboratories Ltd.DIVISLAB (INE361B01024)Pharmaceuticals & Biotechnology8.20%
Glenmark Pharmaceuticals Ltd.GLENMARK (INE935A01035)Pharmaceuticals & Biotechnology6.78%
Lupin Ltd.LUPIN (INE326A01037)Pharmaceuticals & Biotechnology6.65%
Alkem Laboratories Ltd.ALKEM (INE540L01014)Pharmaceuticals & Biotechnology5.99%
Max Healthcare Institute LimitedMAXHEALTH (INE027H01010)Healthcare Services5.96%
Aster DM Healthcare LimitedASTERDM (INE914M01019)Healthcare Services5.70%
Ipca Laboratories Ltd.IPCALAB (INE571A01038)Pharmaceuticals & Biotechnology5.16%
Acutaas Chemicals LimitedACUTAAS (INE00FF01025)Pharmaceuticals & Biotechnology4.39%
Anthem Biosciences LimitedANTHEM (INE0CZ201020)Pharmaceuticals & Biotechnology4.29%
Fortis Healthcare LimitedFORTIS (INE061F01013)Healthcare Services3.49%
Krishna Institute Of Medical Sciences LimitedKIMS (INE967H01025)Healthcare Services3.10%
Laurus Labs Ltd.LAURUSLABS (INE947Q01028)Pharmaceuticals & Biotechnology2.76%
Metropolis Healthcare Ltd.METROPOLIS (INE112L01020)Healthcare Services2.37%
Torrent Pharmaceuticals Ltd.TORNTPHARM (INE685A01028)Pharmaceuticals & Biotechnology2.34%
Eris Lifesciences LtdERIS (INE406M01024)Pharmaceuticals & Biotechnology2.24%
Vijaya Diagnostic Centre LimitedVIJAYA (INE043W01024)Healthcare Services2.13%
Sai Life Sciences LimitedSAILIFE (INE570L01029)Pharmaceuticals & Biotechnology2.09%
Shilpa Medicare LtdSHILPAMED (INE790G01031)Pharmaceuticals & Biotechnology1.91%
Global Health LimitedMEDANTA (INE474Q01031)Healthcare Services1.88%
Dr. Lal Path Labs LtdLALPATHLAB (INE600L01024)Healthcare Services1.57%
Neuland Laboratories LimitedNEULANDLAB (INE794A01010)Pharmaceuticals & Biotechnology1.54%
Wockhardt Ltd.WOCKPHARMA (INE049B01025)Pharmaceuticals & Biotechnology1.54%
Jubilant Pharmova LimitedJUBLPHARMA (INE700A01033)Pharmaceuticals & Biotechnology1.31%
Thyrocare Technologies Ltd.THYROCARE (INE594H01019)Healthcare Services1.27%
Rubicon Research LimitedRUBICON (INE506V01022)Pharmaceuticals & Biotechnology1.24%
Gland Pharma Ltd.GLAND (INE068V01023)Pharmaceuticals & Biotechnology1.07%
BAJAJ HEALTHCARE LIMITEDBAJAJHCARE (INE411U01027)Pharmaceuticals & Biotechnology0.83%
Laxmi Dental LimitedLAXMIDENTL (INE0WO601020)Healthcare Equipment & Supplies0.52%
Portfolio data is as on date 31 March, 2026

NAV history

HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan - 30 days NAV (Net asset value) history

DateNAV% change
6 May, 202619.567 1.69%
5 May, 202619.242 0.23%
4 May, 202619.198 2.04%
30 April, 202618.814 -0.01%
29 April, 202618.815 0.27%
28 April, 202618.764 -0.4%
27 April, 202618.839 2.33%
24 April, 202618.41 -0.96%
23 April, 202618.589 0.74%
22 April, 202618.452 0.41%
21 April, 202618.377 0.07%
20 April, 202618.364 0.01%
17 April, 202618.363 0.39%
16 April, 202618.292 0.07%
15 April, 202618.279 1.83%
13 April, 202617.951 -0.49%
10 April, 202618.04 0.67%
9 April, 202617.92 0.96%
8 April, 202617.75 1.78%
7 April, 202617.439 0.4%
6 April, 202617.37 0.58%
2 April, 202617.269 -1.01%
1 April, 202617.446 -0.27%
31 March, 202617.494 -0.01%
30 March, 202617.495 -1.22%
27 March, 202617.711 -0.33%
25 March, 202617.77 1.94%
24 March, 202617.431 1.43%
23 March, 202617.186 -1.84%
20 March, 202617.508

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan?
    The latest NAV of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan is 19.567 as on 6 May, 2026.
  • What are YTD (year to date) returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan?
    The YTD (year to date) returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan are 10.84% as on 6 May, 2026.
  • What are 1 year returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan?
    The 1 year returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan are 20.35% as on 6 May, 2026.